Connect with us
Kindly follow us on
About Us
About Alkem
Our Values
Code of Ethics
Founder Story
Board of Directors
Leadership Team
Milestones
Awards & Achievements
Offerings
Therapies
Anti - Infective
Anti-Osteoporosis
Cardiology
Neurology
Dermatology
Diabetology
Gastroenterology
Gynaecology
Oncology
Ophthalmology
Respiratory
Rheumatology
Urology
Rx Products
Alkem Generic
International Presence
Overview
US
Australia
Europe
UK
Germany
Latin America
Chile
Colombia
Emerging Market
Kazakhstan
Philippines
UAE
East Africa
French West Africa
South Africa
Francophone
Capabilities
R&D
Research Facilities
Capabilities
Achievements
Manufacturing Facilities
Quality
Facility Tour
Responsibility
ESG
CSR
Alkem Foundation
Thematic Areas
Benificiary Corner
Employee Volunteering
Recognitions and Awards
CSR Annual Report
CSR Action Plan
Investors
Disclosure under Regulation 46 of LODR
Details of Business
Policies
Composition of Committees
Shareholding Pattern
Annual Reports
Quaterly Reports
Notice of Board Meeting
Annual Returns
Subsidiary Financial Statements
Credit Rating
Secreterial Compliance Report
Newspaper Advertisements
Investor/Analyst Meet
Conference Call Invite
Investor Presentations
Earnings Call
Schedule of Investor/Analyst Meet
Disclosure Under Regulations 30
Outcome of Board Meeting
Postal ballot
Annual General Meeting
Other Disclosures
Familiarization Programme
Familiarization Program Policy
Details of Familiarization Program
Contact Details
Investor Greivance
KMP's for Determining Materiality
Financial Overview
Disclosure on Related Party Transaction
Forms
Dividend Details
Careers
Employee Value Proposition
Culture at Alkem
Life at Alkem
Happy Alkemites
Experienced - Early Careers
Work with Us
Media Room
Press Release
News Updates
Corporate Press Kit
Quick Links
Alkem Activa
Ascend Laboratories
Cachet
Enzene
Indchemie
Norac Pharma
Contact Us
Key Contacts
Partnership
Adverse Event Reporting
Kindly follow us on
Connect with us
Home
CSR
Press Release
Press Release
